Efficacy and tolerability of escitalopram in depressed patients with end stage renal disease: an open placebo-controlled study

Objective: This study aimed to investigate the effectiveness and tolerability of escitalopram in the treatment of major depressive disorder (MDD) in patients with end stage renal disease (ESRD). Method: One hundred and forty-five patients with ESRD were screened with Zung depression scale. The pa...

Бүрэн тодорхойлолт

Номзүйн дэлгэрэнгүй

Үндсэн зохиолчид:	Aylin Ertekin Yazıcı, Pervin Erdem, Abdullah Erdem, Şenel Tot Acar, Ayşe Devrim Başterzi, Bahar Taşdelen, Kemal Yazıcı
Формат:	Artigo
Хэл сонгох:	Inglês
Хэвлэсэн:	Mesut Çetin 2021-02-01
Цуврал:	Psychiatry and Clinical Psychopharmacology
Нөхцлүүд:	Escitalopram major depressive disorder end stage renal disease
Онлайн хандалт:	https://psychiatry-psychopharmacology.com/index.php/pub/article/view/1941
Шошгууд:	Шошго нэмэх Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!